1248 Management’s Amgen AMGN Stock Holding History

1248 Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.07M	Sell	2,542 -24	-0.9%	-$9.6K	0.38%	33
2026 Q2	$929K	Hold	2,566	–	–	0.36%	35
2026 Q1	$903K	Buy	2,566 +1,608	+168%	+$573K	0.42%	28
2025 Q4	$314K	Hold	958	–	–	0.17%	70
2025 Q3	$270K	Hold	958	–	–	0.15%	74
2025 Q2	$267K	Sell	958 -63	-6%	-$17.8K	0.1%	84
2025 Q1	$318K	Buy	+1,021	New	+$301K	0.14%	73

Other funds holding AMGN

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

1248 Management's AMGN Position: Q3 2026 in Review

1248 Management reduced its Amgen (AMGN) stake by 0.94% in Q3 2026, selling an estimated $9.6K and leaving 2,542 shares worth $1.07M. The position accounts for 0.38% of the portfolio, ranked #33.

1248 Management first reported a position in AMGN in Q1 2025 and has held it in 7 quarters since. 2,649 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

1248 Management held 2,542 shares of Amgen worth $1.07M as of Q3 2026.
1248 Management sold 24 Amgen shares in Q3 2026, an estimated $9.6K.
Amgen made up 0.38% of 1248 Management's portfolio in Q3 2026, its #33 holding.
1248 Management first reported a position in Amgen in Q1 2025 and has held it in 7 quarters since.
2,649 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on 1248 Management's 13F filing for Q3 2026, filed 12 Nov 2026.